AACR White paper: Shaping the future of cancer prevention - A roadmap for advancing science and public health

Scott M. Lippman, Cory Abate-Shen, Karen L. Colbert Maresso, Graham A. Colditz, Andrew J. Dannenberg, Nancy E. Davidson, Mary L. Disis, Raymond N. DuBois, Eva Szabo, Anna R. Giuliano, William N. Hait, J. Jack Lee, Thomas W. Kensler, Barnett S. Kramer, Paul Limburg, Anirban Maitra, Maria Elena Martinez, Timothy R. Rebbeck, Kathryn H. Schmitz, Eduardo VilarErnest T. Hawk

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The recent pace, extent, and impact of paradigm-changing cancer prevention science has been remarkable. The American Association for Cancer Research (AACR) convened a 3-day summit, aligned with five research priorities: (i) Precancer Atlas (PCA). (ii) Cancer interception. (iii) Obesity-cancer linkage, a global epidemic of chronic low-grade inflammation. (iv) Implementation science. (v) Cancer disparities. Aligned with these priorities, AACR co-led the Lancet Commission to formally endorse and accelerate the NCI Cancer Moonshot program, facilitating new global collaborative efforts in cancer control. The expanding scope of creative impact is perhaps most startling'from NCI-funded built environments to AACR Team Science Awarded studies of Asian cancer genomes informing global primary prevention policies; cell-free epigenetic marks identifying incipient neoplastic site; practice-changing genomic subclasses in myeloproliferative neoplasia (including germline variant tightly linked to JAK2 V617F haplotype); universal germline genetic testing for pancreatic cancer; and repurposing drugs targeting immune- and stem-cell signals (e.g., IL-1b, PD-1, RANKL) to cancer interception. Microbiota-driven IL-17 can induce stemness and transformation in pancreatic precursors (identifying another repurposing opportunity). Notable progress also includes hosting an obesity special conference (connecting epidemiologic and molecular perspectives to inform cancer research and prevention strategies), co-leading concerted national implementation efforts in HPV vaccination, and charting the future elimination of cancer disparities by integrating new science tools, discoveries and perspectives into community-engaged research, including targeted counter attacks on e-cigarette ad exploitation of children, Hispanics and Blacks. Following this summit, two unprecedented funding initiatives were catalyzed to drive cancer prevention research: the NCI Cancer Moonshot (e.g., PCA and disparities); and the AACR-Stand Up To Cancer bold “Cancer Interception” initiative. Cancer Prev Res; 11(12); 735-778. 2018 AACR.

Original languageEnglish (US)
Pages (from-to)735-778
Number of pages44
JournalCancer Prevention Research
Volume11
Issue number12
DOIs
StatePublished - Dec 2018

Fingerprint

Public Health
Research
Neoplasms
Atlases
Obesity
Interleukin-17
Microbiota
Genetic Testing
Primary Prevention
Drug Delivery Systems
Pancreatic Neoplasms
Hispanic Americans
Epigenomics
Tobacco Products
Haplotypes
Vaccination
Stem Cells

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Lippman, S. M., Abate-Shen, C., Colbert Maresso, K. L., Colditz, G. A., Dannenberg, A. J., Davidson, N. E., ... Hawk, E. T. (2018). AACR White paper: Shaping the future of cancer prevention - A roadmap for advancing science and public health. Cancer Prevention Research, 11(12), 735-778. https://doi.org/10.1158/1940-6207.CAPR-18-0421
Lippman, Scott M. ; Abate-Shen, Cory ; Colbert Maresso, Karen L. ; Colditz, Graham A. ; Dannenberg, Andrew J. ; Davidson, Nancy E. ; Disis, Mary L. ; DuBois, Raymond N. ; Szabo, Eva ; Giuliano, Anna R. ; Hait, William N. ; Jack Lee, J. ; Kensler, Thomas W. ; Kramer, Barnett S. ; Limburg, Paul ; Maitra, Anirban ; Martinez, Maria Elena ; Rebbeck, Timothy R. ; Schmitz, Kathryn H. ; Vilar, Eduardo ; Hawk, Ernest T. / AACR White paper : Shaping the future of cancer prevention - A roadmap for advancing science and public health. In: Cancer Prevention Research. 2018 ; Vol. 11, No. 12. pp. 735-778.
@article{958deb5a5a6f4e9e8ac3c34ac8679b71,
title = "AACR White paper: Shaping the future of cancer prevention - A roadmap for advancing science and public health",
abstract = "The recent pace, extent, and impact of paradigm-changing cancer prevention science has been remarkable. The American Association for Cancer Research (AACR) convened a 3-day summit, aligned with five research priorities: (i) Precancer Atlas (PCA). (ii) Cancer interception. (iii) Obesity-cancer linkage, a global epidemic of chronic low-grade inflammation. (iv) Implementation science. (v) Cancer disparities. Aligned with these priorities, AACR co-led the Lancet Commission to formally endorse and accelerate the NCI Cancer Moonshot program, facilitating new global collaborative efforts in cancer control. The expanding scope of creative impact is perhaps most startling'from NCI-funded built environments to AACR Team Science Awarded studies of Asian cancer genomes informing global primary prevention policies; cell-free epigenetic marks identifying incipient neoplastic site; practice-changing genomic subclasses in myeloproliferative neoplasia (including germline variant tightly linked to JAK2 V617F haplotype); universal germline genetic testing for pancreatic cancer; and repurposing drugs targeting immune- and stem-cell signals (e.g., IL-1b, PD-1, RANKL) to cancer interception. Microbiota-driven IL-17 can induce stemness and transformation in pancreatic precursors (identifying another repurposing opportunity). Notable progress also includes hosting an obesity special conference (connecting epidemiologic and molecular perspectives to inform cancer research and prevention strategies), co-leading concerted national implementation efforts in HPV vaccination, and charting the future elimination of cancer disparities by integrating new science tools, discoveries and perspectives into community-engaged research, including targeted counter attacks on e-cigarette ad exploitation of children, Hispanics and Blacks. Following this summit, two unprecedented funding initiatives were catalyzed to drive cancer prevention research: the NCI Cancer Moonshot (e.g., PCA and disparities); and the AACR-Stand Up To Cancer bold “Cancer Interception” initiative. Cancer Prev Res; 11(12); 735-778. 2018 AACR.",
author = "Lippman, {Scott M.} and Cory Abate-Shen and {Colbert Maresso}, {Karen L.} and Colditz, {Graham A.} and Dannenberg, {Andrew J.} and Davidson, {Nancy E.} and Disis, {Mary L.} and DuBois, {Raymond N.} and Eva Szabo and Giuliano, {Anna R.} and Hait, {William N.} and {Jack Lee}, J. and Kensler, {Thomas W.} and Kramer, {Barnett S.} and Paul Limburg and Anirban Maitra and Martinez, {Maria Elena} and Rebbeck, {Timothy R.} and Schmitz, {Kathryn H.} and Eduardo Vilar and Hawk, {Ernest T.}",
year = "2018",
month = "12",
doi = "10.1158/1940-6207.CAPR-18-0421",
language = "English (US)",
volume = "11",
pages = "735--778",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

Lippman, SM, Abate-Shen, C, Colbert Maresso, KL, Colditz, GA, Dannenberg, AJ, Davidson, NE, Disis, ML, DuBois, RN, Szabo, E, Giuliano, AR, Hait, WN, Jack Lee, J, Kensler, TW, Kramer, BS, Limburg, P, Maitra, A, Martinez, ME, Rebbeck, TR, Schmitz, KH, Vilar, E & Hawk, ET 2018, 'AACR White paper: Shaping the future of cancer prevention - A roadmap for advancing science and public health', Cancer Prevention Research, vol. 11, no. 12, pp. 735-778. https://doi.org/10.1158/1940-6207.CAPR-18-0421

AACR White paper : Shaping the future of cancer prevention - A roadmap for advancing science and public health. / Lippman, Scott M.; Abate-Shen, Cory; Colbert Maresso, Karen L.; Colditz, Graham A.; Dannenberg, Andrew J.; Davidson, Nancy E.; Disis, Mary L.; DuBois, Raymond N.; Szabo, Eva; Giuliano, Anna R.; Hait, William N.; Jack Lee, J.; Kensler, Thomas W.; Kramer, Barnett S.; Limburg, Paul; Maitra, Anirban; Martinez, Maria Elena; Rebbeck, Timothy R.; Schmitz, Kathryn H.; Vilar, Eduardo; Hawk, Ernest T.

In: Cancer Prevention Research, Vol. 11, No. 12, 12.2018, p. 735-778.

Research output: Contribution to journalReview article

TY - JOUR

T1 - AACR White paper

T2 - Shaping the future of cancer prevention - A roadmap for advancing science and public health

AU - Lippman, Scott M.

AU - Abate-Shen, Cory

AU - Colbert Maresso, Karen L.

AU - Colditz, Graham A.

AU - Dannenberg, Andrew J.

AU - Davidson, Nancy E.

AU - Disis, Mary L.

AU - DuBois, Raymond N.

AU - Szabo, Eva

AU - Giuliano, Anna R.

AU - Hait, William N.

AU - Jack Lee, J.

AU - Kensler, Thomas W.

AU - Kramer, Barnett S.

AU - Limburg, Paul

AU - Maitra, Anirban

AU - Martinez, Maria Elena

AU - Rebbeck, Timothy R.

AU - Schmitz, Kathryn H.

AU - Vilar, Eduardo

AU - Hawk, Ernest T.

PY - 2018/12

Y1 - 2018/12

N2 - The recent pace, extent, and impact of paradigm-changing cancer prevention science has been remarkable. The American Association for Cancer Research (AACR) convened a 3-day summit, aligned with five research priorities: (i) Precancer Atlas (PCA). (ii) Cancer interception. (iii) Obesity-cancer linkage, a global epidemic of chronic low-grade inflammation. (iv) Implementation science. (v) Cancer disparities. Aligned with these priorities, AACR co-led the Lancet Commission to formally endorse and accelerate the NCI Cancer Moonshot program, facilitating new global collaborative efforts in cancer control. The expanding scope of creative impact is perhaps most startling'from NCI-funded built environments to AACR Team Science Awarded studies of Asian cancer genomes informing global primary prevention policies; cell-free epigenetic marks identifying incipient neoplastic site; practice-changing genomic subclasses in myeloproliferative neoplasia (including germline variant tightly linked to JAK2 V617F haplotype); universal germline genetic testing for pancreatic cancer; and repurposing drugs targeting immune- and stem-cell signals (e.g., IL-1b, PD-1, RANKL) to cancer interception. Microbiota-driven IL-17 can induce stemness and transformation in pancreatic precursors (identifying another repurposing opportunity). Notable progress also includes hosting an obesity special conference (connecting epidemiologic and molecular perspectives to inform cancer research and prevention strategies), co-leading concerted national implementation efforts in HPV vaccination, and charting the future elimination of cancer disparities by integrating new science tools, discoveries and perspectives into community-engaged research, including targeted counter attacks on e-cigarette ad exploitation of children, Hispanics and Blacks. Following this summit, two unprecedented funding initiatives were catalyzed to drive cancer prevention research: the NCI Cancer Moonshot (e.g., PCA and disparities); and the AACR-Stand Up To Cancer bold “Cancer Interception” initiative. Cancer Prev Res; 11(12); 735-778. 2018 AACR.

AB - The recent pace, extent, and impact of paradigm-changing cancer prevention science has been remarkable. The American Association for Cancer Research (AACR) convened a 3-day summit, aligned with five research priorities: (i) Precancer Atlas (PCA). (ii) Cancer interception. (iii) Obesity-cancer linkage, a global epidemic of chronic low-grade inflammation. (iv) Implementation science. (v) Cancer disparities. Aligned with these priorities, AACR co-led the Lancet Commission to formally endorse and accelerate the NCI Cancer Moonshot program, facilitating new global collaborative efforts in cancer control. The expanding scope of creative impact is perhaps most startling'from NCI-funded built environments to AACR Team Science Awarded studies of Asian cancer genomes informing global primary prevention policies; cell-free epigenetic marks identifying incipient neoplastic site; practice-changing genomic subclasses in myeloproliferative neoplasia (including germline variant tightly linked to JAK2 V617F haplotype); universal germline genetic testing for pancreatic cancer; and repurposing drugs targeting immune- and stem-cell signals (e.g., IL-1b, PD-1, RANKL) to cancer interception. Microbiota-driven IL-17 can induce stemness and transformation in pancreatic precursors (identifying another repurposing opportunity). Notable progress also includes hosting an obesity special conference (connecting epidemiologic and molecular perspectives to inform cancer research and prevention strategies), co-leading concerted national implementation efforts in HPV vaccination, and charting the future elimination of cancer disparities by integrating new science tools, discoveries and perspectives into community-engaged research, including targeted counter attacks on e-cigarette ad exploitation of children, Hispanics and Blacks. Following this summit, two unprecedented funding initiatives were catalyzed to drive cancer prevention research: the NCI Cancer Moonshot (e.g., PCA and disparities); and the AACR-Stand Up To Cancer bold “Cancer Interception” initiative. Cancer Prev Res; 11(12); 735-778. 2018 AACR.

UR - http://www.scopus.com/inward/record.url?scp=85058267251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058267251&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-18-0421

DO - 10.1158/1940-6207.CAPR-18-0421

M3 - Review article

C2 - 30530635

AN - SCOPUS:85058267251

VL - 11

SP - 735

EP - 778

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 12

ER -

Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE et al. AACR White paper: Shaping the future of cancer prevention - A roadmap for advancing science and public health. Cancer Prevention Research. 2018 Dec;11(12):735-778. https://doi.org/10.1158/1940-6207.CAPR-18-0421